Background: Fas, a member of the tumor necrosis family, is responsible for initiating the apoptotic pathway when bound to its ligand, Fas-L. Defects in the Fas-mediated apoptotic pathway have been reported in colorectal cancer.
Introduction
Apoptosis is a regulated process that eliminates individual cells that are damaged or infected. There are several signals capable of triggering apoptosis, of which the activation of Fas/CD95/Apo-1 receptor (Fas) by Fas ligand (Fas-L) is the most studied [1] . Most information about the Fas pathway is based on the immune system, where Fas is highly expressed in activated T and B cells, thymocytes, and lung and liver cells [2] . Cloning of the Fas receptor (lpr) [3] and the Fas-L (gld) [4] genes led to studies involving their potential roles in the activation of the apoptotic pathway by death receptors. From these studies, a potential mechanism evolved in which interaction of Fas-L with Fas results in a conformational change of the receptor resulting in the assembly of the death-inducing signaling complex, which is able to recruit and cleave procaspase-8 (reviewed in [5] ).
During colon cancer, regulation of the Fas system facilitates tumor development. Some studies have shown that resistance of colon carcinoma cells to apoptosis can be attributed to the elevated expression of Fas-associated phosphatase-1 [6] , which inhibits Fas signaling by binding to the cytoplasmic tail of Fas. Another factor that may contribute to apoptosis resistance is incomplete Fas surface expression, with appropriate Fas mRNA levels but deficient posttranslational processing, attenuating its cell surface expression and remaining inactivated [7] . Amplification of a decoy receptor for Fas-L in lung and colon cancer has also been reported [8] . A number of investigations have proposed a ''Fas counterattack'', which is thought to be an anti-host tumor-derived response [9] , where lymphocyte proliferation is compromised by tumor cells expressing Fas-L. This induces apoptosis in the lymphocytes, sparing tumor cells due to another mechanism, i.e., low Fas surface expression [10, 11, 12] . This notion however, remains controversial, and has been refuted by some investigators [13] and contradicted by other in vivo studies [14, 15, 16, 17] .
The adenomatous polyposis coli multiple intestinal neoplasia (Apc Min/+ ) mouse model presents phenotypes reminiscent of Familial Adenomatous Polyposis (FAP) in humans [18, 19] . Patients with FAP develop multiple adenomas in the large intestine, which lead to the development of malignant adenocarcinomas. The relevance of the Apc Min/+ mouse model is that most colorectal cancers also show alterations in expression of the Apc gene [20, 21] . Apc is a gatekeeper that regulates the levels of bcatenin [22] , a transcription factor that has Matrix metalloproteinase-7 [23] among its target genes. In the current study, Apc Min/+ mice were crossed with Fas deficient (Fas lpr ) mice to generate Apc Min/+ / Fas lpr mice in order to study the effect of a disrupted Fas-mediated apoptotic machinery on tumor development and progression. The results are summarized herein.
Material and Methods

Mice and Tissue Processing
The animal protocols used in this study were approved by (8, 12, 16, 20 , and 30 weeks) in a C57BL/6 background, were used for all analyses. Tumor counting was performed under a dissecting microscope by investigators blinded to the genotype. Intestines were opened longitudinally, cleaned, Swiss-rolled, fixed with periodate-lysine-paraformaldehyde (PLP), and embedded in paraffin.
Blood Analysis
Blood extracted intravenously from individual mice was treated with EDTA and an aliquot (50 ml) was applied to an automated CBC analyzer (Hemavet HV950FS, Drew Scientific, Oxford, CT, USA) in order to determine the number of leukocytes (lymphocytes, neutrophils, monocytes), erythrocytes (red blood cells, hemoglobin and hematocrit), and thrombocytes (platelets).
Histochemistry and Immunohistochemistry
Serial sections of paraffin-embedded tissue were cut for haematoxylin and eosin (H&E) staining and for immunostaining. Active caspase-3 and Fas-L were identified utilizing polyclonal rabbit-anti-human active caspase-3 and Fas-L antibodies (Abcam, Cambridge, MA), followed by HRP-conjugated goat-anti-rabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA). PCNA was identified utilizing a monoclonal mouse-anti-human PCNA antibody (BioGenex, San Ramon, CA) as the primary antibody, followed by HRP-conjugated rabbit-anti-mouse IgG (Santa Cruz Biotechnology). A mouse monoclonal-anti-mouse p53 antibody (Abcam) was used to detect p53, followed by HRP-conjugated rabbit-anti-mouse IgG (AbD Serotec, Oxford, UK). Total Akt and phosphorylated Akt were identified utilizing polyclonal rabbit-antimouse Akt and pAkt antibodies (Abcam and Cell Signaling, Danvers, MA, respectively), followed by biotinylated swine-antirabbit IgG (Dako, Carpinteria, CA) and HRP-conjugated streptavidin (BioGenex). CD45 and Mac-3 were identified utilizing a monoclonal rat-anti-mouse antibodies for CD45 and Mac-3 (Pharmingen, San Diego, CA), followed by a biotinylated rabbitanti-mouse IgG (Dako, Carpinteria, CA) and HRP conjugated streptavidin (Jackson, West Grove, PA). Phosphorylated Foxo3a was identified utilizing a polyclonal rabbit-anti-rat Foxo3a (phosphor S253) antibody (Abcam), followed by HRP-conjugated goat-anti-rabbit IgG (Santa Cruz Biotechnology). All stains were then developed in 3, 39-diaminobenzidine (DAB) and a haematoxylin QS counterstain was applied (Vector Laboratories, Burlington, CA).
Stain Quantification and Statistical Analysis
Immunohistochemical stains were quantified using Spectrum Plus (Version 9.0.748.1518) and ImageScope software (Aperio Technologies, Vista, CA). Slides were scanned and loaded into an Scanned slides were viewed in ImageScope where regions were drawn around each tumor and analyzed with Spectrum software, using algorithms designed for each stain. Stains using percent positive area were analyzed using color deconvolution algorithms. Stains requiring the number of positive cells per tumor area were analyzed using algorithms that separate color by optical density and also separate cells by outer membrane size and roundness. Cells that fit within the parameters set for desired cell size and shape and stain were counted, as was the area of each tumor region. The average number of cells per tumor area was then determined.
Statistical Analysis
For survival studies, the data were analyzed using the KaplanMeier treatment and the comparison of survival between both genotypes was performed using the log-rank test with Prism 4 software (GraphPad Software, La Jolla, CA). The Student's t-test was used for comparison of single pairs. , and reaching a plateau of slightly more than 70 adenomas after 16 weeks of age (Fig. 1A) (Fig. 2) . The invasive lesions are not to be confused with herniation, a common occurrence in Apc Min/+ mice. All specimens were analyzed by a veterinary pathologist utilizing standardized guidelines [25] . The percentage of invasive lesions ranged from 3.0 to 15.4% (Table 1) . However, metastasis to other organs was not detected.
Results
Fas Deletion in
Adenomas from Apc
Min/+ /Fas lpr Mice Show Increased Proliferation
To determine if increased polyps in the Apc Min/+ /Fas lpr mice were due to an increase in cellular proliferation and/or a decrease in apoptosis, cells positive for proliferating cell nuclear antigen (PCNA) (Fig. 3) (Fig. 6B) . Mac-3, an antigen present on macrophages, had the same trend with lower levels in tumors of Apc Min/+ mice (6236166 +cells/mm 2 , n = 21 in 4 mice) than in Apc Min/+ /Fas lpr mice (58046175 +cells/mm 2 , n = 151 in 5 mice) (p,0.0001).
In addition to PCNA, cell survival was further analyzed by staining for total Akt and its activated phosphorylated form (p-Akt) (Fig. 6A) . The stains revealed a predictable trend in which tumors from Apc Min/+ /Fas lpr mice showed higher levels of Akt (63.8%67.6 n = 199 in 5 mice, versus 40.6%64.1, n = 21 in 4 mice) and pAkt (53.0%610.8, n = 186 in 5 mice, versus 13.7%62.0, n = 28 in 5 mice) than Apc Min/+ mice (p,0.0001) (Fig. 6B) . Akt is reported to decrease expression of Fas-L by phosphorylating and, therefore, inhibiting Foxo3a, a member of the forkhead family of transcription factors responsible for Fas-L expression [26, 27] . In accordance with those reports, levels of phosphorylated Foxo3a (p- (Fig. 6A,B) .
Hematology Profile
Prior to perfusion, blood was collected from all animals for hematological profiling. Measurements of leukocyte (neutrophils, lymphocytes, and monocytes) levels revealed that the averages remained within the normal ranges (data not shown).
Apc Min/+ /Fas lpr mice, at most time points, were anemic as determined by red blood cell counts, hemoglobin, and percent hematocrit. However, Apc
Min/+ mice, as well as Fas lpr mice were also anemic. Platelets, in all cases, were within normal ranges (data not shown). 
Discussion
This study demonstrated that Apc Min/+ mice develop more intestinal adenomas when Fas is absent. An increase in proliferation (measured by PCNA) was evident, especially at later time points where an increase in Akt and pAkt was also observed. Additionally, there was a decrease in Fas-L in Apc Min/+ /Fas lpr mice. A significant increase in inflammation and Mac-3 was also observed in tumors of Apc Min/+ /Fas lpr mice.
In the present study it was observed that at all time points (8, 12, 16, 20 and 30 weeks), Apc Min/+ mice developed substantially more intestinal adenomas when Fas was eliminated. These adenomas also proved to be more aggressive. Incidences of intestinal prolapse were common in the Apc Min/+ /Fas lpr mice, especially at the later time points. Overall, the poor health of these animals was evidenced by their diminished survival rate as they approached 30 weeks of age. These findings were not surprising and were in accord with expectations from disruption of the apoptotic pathway [28] . However, the levels of the apoptotic markers, activated caspase-3 and p53, were unexpected. There were no differences in activated caspase-3 levels, but an increase in p53 levels was observed in Apc Min/+ /Fas lpr mice compared to Apc Min/+ mice. Changes in cleaved caspase-3 were also absent in previous studies using Apc Min/+ mice lacking Fas-L [17] . On the other hand, p53, also an apoptotic marker, was higher in tumors of Apc Min/+ /Fas lpr mice compared to Apc Min/+ mice at early time points. However, this difference was attenuated at 30 weeks, when Akt and pAkt were observed to be higher in Apc mice. Akt is a protein kinase activated by a variety of growth factors [29, 30] that in turn triggers activation of several cancerrelevant downstream effector molecules, resulting in an environment that promotes proliferation and cell survival [31] . It has previously been reported that Akt is capable of downregulating p53 through phosphorylation of Mdm2 that results in a translocation to the nucleus [32, 33] . The increase of p53 might also be a compensatory mechanism for a lack of Fas pathway. The interdependence between Fas and p53 pathways has been demonstrated by others [34, 35] .
In accordance with reports indicating that Akt regulation in Fas-L expression is due to phosphorylation and, therefore, cytoplasmic retention of the forkhead transcription factor FKHRL1/Foxo3a [26, 27] expression has also been reported in liver metastasis of colon cancer compared to the primary tumor [38] . Those findings might represent a compensatory mechanism for a disrupted Fas-mediated apoptotic pathway. Despite the general assumption that high levels of Fas-L would induce inflammation within the tumors, in the present study it was observed that Apc Min/+ /Fas lpr mice, which had far lower levels of Fas-L than Apc Min/+ mice, showed an increase in inflammation at 30 weeks of age. The mechanism behind the increased level of inflammation in tumors of Apc Min/+ /Fas lpr mice is likely related to a balance between membrane Fas-L (mFas-L) and soluble Fas-L (sFas-L) (Fig. 7) . mFas-L is a well known inducer of inflammation while sFas-L has the opposite effect [39] . Mmp7 is capable of cleaving mFas-L to yield sFas-L [40] . The Apc Min/+ mouse model and colon cancer in general show elevated levels of matrilysin [41, 42] . Therefore, it is not unlikely to assume that in this context the balance between mFas-L and sFas-L would favor its soluble form and therefore a direct correlation between Fas-L and inflammation levels would be expected, as was observed in the present study. Fas-L expression is regulated by Foxo3a, a member of the forkhead family of transcription factors. Akt has been reported to decrease Fas-L expression by phosphorylation and therefore inactivation of Foxo3a. In accord with this mechanism, Apc Min/+ / Fas lpr mice showed higher levels of Akt, p-Akt, and p-Foxo3a, and lower levels of Fas-L.
A relationship between inflammation and cancer has been identified in a number of studies, and it is widely accepted that inflammation creates conditions that promote tumor development (reviewed in [43] ). Furthermore, Mac-3, an antigen present on macrophages, was present at higher levels in tumors of Apc Min/+ / Fas lpr mice and their presence within tumors promoted tumor growth, invasion, and metastasis [44, 45] .
The results of the present study correlate to those of Fingleton et al. [17] with differences that are worthy of further consideration. Fingleton et al. used 17 week Apc Min/+ mice lacking Fas-L instead of its receptor, Fas. Both studies detected high levels of Fas-L in Apc Min/+ mice. While deficiencies of either Fas or FasL resulted in an increase in tumor burden, in the current study, the increases in tumor number ranged from ,300%, at early time points, to over 500%, at 16 weeks, whereas Fingleton et al. observed an increase nearly 100% at 17 weeks. These differences in tumor burden are most likely associated with difference in the inflammatory response observed in these studies. Fingleton et al. did not observe any significant changes in macrophage or lymphocyte infiltration, but did see a 3-fold decrease in neutrophils in Apc Min/+ mice lacking Fas-L. In contrast, the current study demonstrated an obvious increase in the inflammatory response in Apc Min/+ /Fas lpr mice. This supports the premise that the role played by in inflammation is more relevant in tumor development than it is in tumor evasion of the immune system. The current study, however, suggests that in intestinal adenomas, the balance between mFas-L and sFas-L levels, resulting from Mmp7 proteolysis, may regulate the pro-or anti-inflammatory properties of Fas-L.
Among Min/+ mouse model. It is likely that invasive lesions arise, at least in part, as a result of an increase in Akt and its active form, since this kinase has been shown to be involved in tumor invasion and metastasis [46, 47, 48] .
In summary, this study demonstrated that an additional Fas deficiency in Apc Min/+ mice causes a dramatic increase in the number of intestinal tumors. The increase in the incidence of adenoma development and the invasiveness of these adenomas, paralleling a decrease in Fas-L in these mice, does not support the Fas counterattack notion in this model. The increase in Mac-3 and CD45 suggests a tumor permissive environment caused by a Fas-L modulated inflammation.
